- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.10. | Pharmacorp Rx Inc: Pharmacorp Rx appoints Hodson as CFO | 1 | Stockwatch | ||
| 14.10. | PharmaCorp RX appoints new CFO | 2 | Seeking Alpha | ||
| PHARMACORP RX Aktie jetzt für 0€ handeln | |||||
| 27.08. | Pharmacorp Rx Inc: Pharmacorp to make board changes | 2 | Stockwatch | ||
| 27.08. | Pharma Corp Rx Inc.: PharmaCorp Rx Inc. Announces Board and Committee Changes | 289 | GlobeNewswire (Europe) | SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (TSXV: PCRX) ("PharmaCorp" or the "Corporation") today announced changes to its Board of Directors, Board committee leadership... ► Artikel lesen | |
| 20.08. | PharmaCorp Rx reports Q2 results | 1 | Seeking Alpha | ||
| 20.08. | Pharma Corp Rx Inc.: PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results | 497 | GlobeNewswire (Europe) | Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025Second quarter same-store sales were... ► Artikel lesen | |
| 18.08. | PharmaCorp RX Inc.: PharmaCorp Closes Previously Announced Western Canada Pharmacy Acquisition and Announces Two Additional Definitive Agreements | 382 | Newsfile | Purchase price of approximately $2.47 millionAcquisition increases PharmaCorp's operating network to 16 pharmaciesNew definitive share purchase agreement executed for a PharmaChoice Canada-bannered... ► Artikel lesen | |
| 31.07. | Pharmacorp Rx Inc: Pharmacorp Rx closes acquisition of Ontario pharmacy | 1 | Stockwatch | ||
| 31.07. | PharmaCorp RX Inc.: PharmaCorp Closes Previously Announced Ontario Pharmacy Acquisition and Provides Update | 3.645 | Newsfile | Purchase price of approximately $8.1 millionAcquisition increases PharmaCorp's operating network to 15 pharmacies Previously announced second definitive share purchase agreement has received preliminary... ► Artikel lesen | |
| 28.07. | Pharmacorp Rx Inc: Pharmacorp Rx 22,549,200-share prospectus offering | 1 | Stockwatch | ||
| 15.07. | Pharmacorp Rx Inc: Pharmacorp Rx closes $11.5-million public offering | 1 | Stockwatch | ||
| 08.07. | Pharmacorp Rx Inc: Pharmacorp Rx arranges $10-million public offering | 2 | Stockwatch | ||
| 07.07. | PHARMACORP RX launches C$10M bought-deal offering | 2 | Seeking Alpha | ||
| 06.07. | Pharmacorp Rx Inc: Pharmacorp closes eight-store acquisition | 1 | Stockwatch | ||
| 29.06. | Pharmacorp Rx Inc: Pharmacorp firms deal to acquire Pharmachoice pharmacy | 1 | Stockwatch | ||
| 29.06. | PharmaCorp RX Inc.: PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy | 454 | Newsfile | Purchase price of approximately $2.47 million Second of four previously announced letters of intent (LOIs) converted into a definitive agreementOn closing, expected to increase PharmaCorp's store... ► Artikel lesen | |
| 05.06. | PharmaCorp Rx reports Q1 results | 1 | Seeking Alpha | ||
| 01.06. | Pharma Corp Rx Inc.: PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results | 233 | GlobeNewswire (Europe) | First quarter 2026 revenue up 79.4% compared to the first quarter of 2025First quarter 2026 gross profit increased 71.9% compared to the first quarter of 2025First quarter same-store sales were up... ► Artikel lesen | |
| 25.05. | Pharmacorp Rx Inc: Pharmacorp signs definitive agreement for acquisition | 4 | Stockwatch | ||
| 02.05. | Pharmacorp Rx Inc: Pharmacorp Rx closes acquisition of pharmacy files | 1 | Stockwatch |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 43,480 | +0,18 % | Frist statt Freibrief: Was der EU-Pestizidbeschluss für Bayer, BASF und MustGrow Biologics bedeutet | Erstellt und veröffentlicht im Auftrag von MustGrow Biologics. Der Rat der Europäischen Union positionierte sich am 30. September 2026 gegen unbefristete Zulassungen für synthetische Pflanzenschutzmittel... ► Artikel lesen | |
| MERCK KGAA | 146,40 | +1,42 % | Aktie wird zerlegt: BioNTech verfehlt Krebsziel - aber leben Patienten mit der Therapie länger? | © Foto: picture alliance / Laci Perenyi | Laci PerenyiDas erste Hauptziel der Krebsstudie ist verfehlt. Doch die entscheidende Frage bleibt offen: Kann BNT113 das Leben der Patienten verlängern Enthaltene... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,870 | +0,04 % | Teva: Uvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen | |
| IAMBIC THERAPEUTICS | 16,000 | -0,06 % | Biotech an der Börse: Iambic-IPO bringt 150 Millionen USD für Krebsmedikamente | Das US-Biotechunternehmen Iambic setzt bei neuen Krebsmedikamenten auf künstliche Intelligenz. Mit dem frischen Börsenkapital will es klinische Studien voranbringen und seine Forschungstechnik ausbauen.... ► Artikel lesen | |
| KARDIGAN | 13,510 | 0,00 % | Kardigan stock initiated at Outperform by William Blair on pipeline | ||
| SCHOTT PHARMA | 26,000 | +1,96 % | SCHOTT Pharma mit PAUKENSCHLAG: Kaufen Insider bereits massiv? - Unbedingt noch vor Börsenschluss lesen! | ||
| ETON PHARMACEUTICALS | 50,15 | -0,08 % | Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug | ||
| OMNIAB | 4,955 | 0,00 % | OmniAb auf der LD Micro Konferenz: Lizenzgebühren, Skalierung und Geduld im Fokus | ||
| AQUESTIVE THERAPEUTICS | 4,060 | +0,25 % | H.C. Wainwright bekräftigt Kaufempfehlung für Aquestive nach FDA-Fortschritten | ||
| BIOHAVEN | 11,805 | -0,13 % | Biohaven Ltd. - 8-K, Current Report | ||
| LB PHARMACEUTICALS | 41,000 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals to Participate in Upcoming Investor Events | ||
| GENERATE BIOMEDICINES | 12,905 | +0,04 % | Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market | ||
| BRIGHT MINDS BIOSCIENCES | 55,21 | 0,00 % | Levoit and Cosori: 5 Back to School Wellness Heroes for the Bright Minds of Tomorrow | DUBAI, UAE, Aug. 21, 2026 /PRNewswire/ -- Levoit and Cosori unveil five smart home solutions to tackle back to school stresses: polluted indoor air, relentless AC dryness, post snack floor... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 19,240 | -0,21 % | Seaport Therapeutics, Inc.: Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo at the 39th European College of Neuropsychopharmacology (ECNP) Congress | First scientific presentation of detailed PK data demonstrates dose-dependent increases in agomelatine exposure, no food effect, and no accumulation of exposure over seven days of dosing Detailed... ► Artikel lesen | |
| APNIMED | 18,530 | +0,11 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen |
PHARMACORP RX INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMACORP RX INC finden Sie auf Wallstreet Online.